The MAVEN Senior Scientist Initiative

计划入组 160 人 · 首次发布于 2021 年 12 月 28 日

Real-World Effectiveness of Mavacamten in Canada

计划入组 115 人 · 首次发布于 2024 年 3 月 29 日

Venclose digiRF System Post Market Study

计划入组 203 人 · 首次发布于 2022 年 8 月 17 日

Cladribine(Litak, Mavenclad)

C₁₀H₁₂ClN₅O₃ · Rx

LUCA-31 antibody (Raven)

LUCA-38 antibody (Raven)

New Haven Pharmaceuticals, Inc.

United States

Magnitude Biosciences Secures £700K to Advance High-Throughput Drug Discovery Platform

Laverock Therapeutics Raises £20M in Expanded Seed Funding, Reports Positive Data for Cancer Cell Therapy Programs

Arena BioWorks Shuts Down After Less Than Two Years, Citing Policy Uncertainty and Funding Challenges